About B. coagulans

Bacillus coagulans is a lactic acid forming bacteria. It displays behaviors common to both Lactibacillus bacteria as well as Bacillus and was only recently transferred from genus Lactobacillus to Bacillus.

Possible Benefits

There are also references to use of this bacterium in humans, especially in improving the vaginal flora, improving abdominal pain and bloating in Irritable Bowel Syndrome patients and increasing immune response to viral challenges. The bacterium has also been assessed for safety as a food ingredient. Spores are activated in the acidic environment of the stomach and begin germinating and proliferating in the intestine.

Sources:

1. ^ Sanders, M. E.; Morelli, L.; Tompkins, T. A. (2003). “Sporeformers as Human Probiotics: Bacillus, Sporolactobacillus, and Brevibacillus”. Comprehensive Reviews in Food Science and Food Safety 2: 101. doi:10.1111/j.1541-4337.2003.tb00017.x. edit
2. ^ Hong et al., 2005; SCAN
3. ^ https://www.newcenturyhealthpublishers.com/probiotics_and_prebiotics/about/pdf/3-10.pdf
4. ^ Hun, L. (2009). “Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS”. Postgraduate medicine 121 (2): 119–124. doi:10.3810/pgm.2009.03.1984. PMID 19332970. edit
5. ^ Baron, M. (2009). “A patented strain of Bacillus coagulans increased immune response to viral challenge”. Postgraduate medicine 121 (2): 114–118. doi:10.3810/pgm.2009.03.1971. PMID 19332969. edit
6. ^ Endres, J. R.; Clewell, A.; Jade, K. A.; Farber, T.; Hauswirth, J.; Schauss, A. G. (2009). “Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient”. Food and Chemical Toxicology 47 (6): 1231. doi:10.1016/j.fct.2009.02.018. PMC 2726964. PMID 19248815. edit